8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2023 / Expert panel statement / narrative review
An expert panel assessed the potential atherogenicity of phytosterols (PSs) based on metabolism, animal, and human data. Consuming PS-enriched foods increases plasma PSs by ~35%, whereas homozygous phytosterolemia patients exhibit ~4000% higher concentrations where atherosclerosis prevalence is variable and may relate mainly to concomitant elevated LDL-C. Observational studies demonstrate no evidence linking plasma PS concentrations to increased atherosclerosis or cardiovascular events. Because PSs lower LDL-C without adverse safety signals, they offer a dietary approach to cholesterol management, though clinical benefits have not been established in long-term cardiovascular endpoint studies.
Windler E, Beil FU, Berthold HK, et al. Nutrients, 2023. PMID 36839186
2023 / Narrative review
This review summarizes recent in vitro, in vivo, and epidemiological evidence regarding glyphosate toxicity across animal species. While glyphosate targets the shikimate pathway absent in higher animals, its potential toxicity and carcinogenicity in humans remain heavily debated following the 2015 IARC ruling. The authors discuss the literature's implications for broader conversations on human and environmental health.
Shows an association, not proof of cause and effect.
Lacroix R, Kurrasch DM Toxicol Sci, 2023. PMID 36857578
2023 / Review
This review evaluates the evidence surrounding the six pillars of lifestyle medicine on neurocognitive decline. Plant-based nutrition has a positive impact on cognition by decreasing Alzheimer's disease risk with high adherence to the MIND diet. Higher perceived stress in adulthood and risky substances (alcohol, nicotine, and opioids) were significantly associated with mild cognitive impairment and all-cause dementia, while poor sleep and social isolation positively correlated with rapid progression in cognitive decline.
Jaqua E, Biddy E, Moore C, et al. Cureus, 2023. PMID 36883088
2023 / Scoping review of clinical trials
A scoping review evaluated 389 citations from human clinical trials investigating the effects of oral curcumin on disease outcomes. Nearly half the citations focused on obesity-associated metabolic disorders (29%) or musculoskeletal disorders (17%), with beneficial effects on clinical outcomes and/or biomarkers reported in 75% of these studies (77% of which were double-blind randomized placebo-controlled trials). Trials on neurocognitive (11%), gastrointestinal (10%), or cancer (9%) categories were fewer and reported mixed results depending on study quality and condition. The authors noted the need for systematic evaluation of diverse formulations and doses in larger trials.
Panknin TM, Howe CL, Hauer M, et al. Int J Mol Sci, 2023. PMID 36901908
2023 / Narrative review
Epidemiological studies over the past decade consistently associate coffee consumption with positive health outcomes in patients with chronic liver disease, including decreased liver-related mortality. Because coffee contains many constituent molecules influenced by source, roasting, and preparation, identifying its mechanisms of action has been challenging. While caffeine acting as a liver adenosine receptor antagonist is hypothesized as a primary active factor, data also suggest caffeine-independent mechanisms. This review evaluates the biological plausibility of these caffeine-independent effects.
Shows an association, not proof of cause and effect.
Dranoff JA Am J Physiol Gastrointest Liver Physiol, 2023. PMID 36976807
2023 / Narrative review of author studies and literature
This review describes the rationale for using a plant-based diet (PBD, specifically a lacto-ovo-vegetarian diet) in inflammatory bowel disease (IBD) and reviews the authors' modality in Japan. Infliximab and PBD as first-line therapy for newly developed Crohn's disease (CD) achieved a 96% remission rate and yielded a relapse-free course in 52% of patients. The authors assert that IBD is linked to dietary westernization and recommend PBD as part of IBD therapy.
Chiba M, Morita N Metabolites, 2023. PMID 36984772
2023 / Narrative review / clinical guidance
This review addresses clinical evaluation of symptomatic patients following plant-based diets. It notes that poorly-designed restrictive diets may predispose individuals to nutritional deficiencies, with potential deficiencies in macronutrients (protein, essential fatty acids) and micronutrients (vitamin B12, iron, calcium, zinc, and vitamin D). The authors translate seven key nutrient concerns into practical questions for practitioners to incorporate into clinical reasoning and patient counseling.
Plotnikoff GA, Dobberstein L, Raatz S Nutrients, 2023. PMID 36986117
2023 / Scoping review of 23 studies
A scoping review examined 23 papers evaluating nutrition education interventions for medical students and residents. Of 21 interventions designed to increase nutrition knowledge, 18 found significant improvements post-intervention, whereas only 4 of 11 studies assessing attitudes showed meaningful improvement. Self-efficacy was evaluated in 13 studies (56.5%), with 11 reporting significant increases in participants' self-efficacy to offer nutrition care post-intervention, and 7 interventions observed significant improvements in dietary and lifestyle habits. Follow-up evaluations indicated reductions in nutrition knowledge, attitude, and self-efficacy scores.
Mogre V, Amoore BY, Gaa PK J Nutr Sci, 2023. PMID 37008413
2023 / Scientific statement / narrative review
This American Heart Association scientific statement assessed the alignment of commonly practiced US dietary patterns with the 2021 AHA dietary guidance criteria. Several dietary patterns strongly aligned with the guidance, specifically Mediterranean, DASH, pescetarian, and vegetarian diets. The statement highlights that these patterns can be adapted to personal, cultural, and budgetary needs, and optimal cardiovascular health requires supporting food environments where food is prepared or consumed.
Gardner CD, Vadiveloo MK, Petersen KS, et al. Circulation, 2023. PMID 37128940
2023 / Narrative review of studies from 2015 to date
This review evaluated literature from 2015 to date regarding glyphosate occurrence, environmental and occupational exposure, and epidemiological cancer risk in humans. The reviewed studies indicated that herbicide residues were detectable globally and showed an increase in glyphosate concentrations in biofluids among both general and occupationally exposed populations. However, epidemiological studies provided limited evidence regarding the carcinogenicity of glyphosate, aligning with the International Agency for Research on Cancer's classification of it as a probable carcinogen.
Shows an association, not proof of cause and effect.
Muñoz JP, Silva-Pavez E, Carrillo-Beltrán D, et al. Environ Res, 2023. PMID 37209985
2023 / Case reports and literature review
Two cases of acute kidney injury considered to be due to oxalate nephropathy after purslane (portulaca oleracea) ingestion are reported along with a literature review. Both elderly patients presented with oliguria, nausea, vomiting, and acute kidney injury requiring renal replacement therapy. A renal biopsy in one patient revealed acute tubulointerstitial injury and partial tubular oxalate deposition. Both patients underwent hemodialysis and were discharged following improvement in creatinine levels.
Shows an association, not proof of cause and effect.
Wang X, Zhang X, Wang L, et al. BMC Nephrol, 2023. PMID 37443012
2023 / Narrative review and market survey
This review evaluated the nutritional, processing, and bioactivity aspects of soy-derived beverages, alongside a market survey of 52 commercial soy beverages in Spain and other European countries. Calcium and vitamin-fortified drinks represented the predominant category, comprising 60% of the evaluated market. The authors also synthesized evidence from studies and meta-analyses on the health effects of soy beverage components (including isoflavones, proteins, fiber, and oligosaccharides) and addressed controversies surrounding growth, puberty, fertility, feminization, and thyroid function.
Olías R, Delgado-Andrade C, Padial M, et al. Foods, 2023. PMID 37509757
2023 / Narrative review
This review frames the interrelationship between heavy menstrual bleeding (HMB), iron deficiency (ID), and iron deficiency anemia (IDA) in reproductive-aged girls and women. Both HMB and ID/IDA impair quality of life and cognitive function, contributing to work and school absenteeism and presenteeism. Furthermore, evidence suggests that ID in early pregnancy may adversely affect fetal neurodevelopment with lasting cognitive and psychological effects. The author calls for diagnostic and management guidelines to identify ID, replete iron stores, and treat underlying causes of HMB.
Munro MG Int J Gynaecol Obstet, 2023. PMID 37538011
2023 / Narrative review
This review examines the potential role of inorganic phosphate food additives as contributors to the adverse effects of ultra-processed foods on cardiorenal disease. Inorganic phosphates are rapidly and efficiently absorbed, and elevated serum phosphate can directly lead to tissue or vessel calcification or indirectly act through mineral-regulating hormones like parathyroid hormone and fibroblast growth factor-23. While associations between serum phosphate, dietary phosphate intake, and mortality are noted in epidemiological studies, the exact magnitude of the role of these additives remains to be determined.
Shows an association, not proof of cause and effect.
Calvo MS, Dunford EK, Uribarri J Nutrients, 2023. PMID 37630701
2023 / Narrative review
This review evaluates the pros and cons of newer weight loss medications like semaglutide and tirzepatide, noting short-term weight losses of -15% to -20% from baseline. The authors note that profound caloric reductions from these medications should prompt baseline or ongoing nutritional deficiency testing and dietary recommendations. However, long-term adherence, cost, access, supply chain issues, and long-term impacts on mental and physical health remain unknown.
Moyad MA Curr Urol Rep, 2023. PMID 37659049
2023 / Narrative review
This review summarizes scientific milestones and therapies developed to address obesity and its cardiometabolic comorbidities. It highlights key developments starting from the discovery of leptin, melanocortin receptor agonists for syndromic obesity, incretin therapies including GLP-1 analogs and unimolecular combinations, and metabolic and bariatric surgery. The authors emphasize that this expanding therapeutic armamentarium warrants a coordinated multidisciplinary approach, such as cardiometabolic expertise centers, to address obesity and its complications.
Kokkorakis M, Katsarou A, Katsiki N, et al. Metabolism, 2023. PMID 37689110
2023 / Interdisciplinary, multi-stakeholder workshop proceedings
An interdisciplinary workshop brought together experts from government, academia, and industry to establish a Research Roadmap concerning processed food intake and obesity and cardiometabolic disease risk in the United States. Attendees highlighted challenges related to heterogeneity and subjectivity in ultra-processed food (UPF; Nova Group 4) classification. They developed six key research questions addressing objective UPF categorization, exposure assessment improvements, independence from diet quality, impacts on ingestive behavior, metabolic responses, and external environmental drivers. The authors conclude that further causal, mechanistic, and methodological research is warranted.
O'Connor LE, Higgins KA, Smiljanec K, et al. Adv Nutr, 2023. PMID 37722488
2023 / Commentary / expert opinion
Mathilde Touvier and colleagues argue that an incomplete understanding of the multiple mechanisms linking ultra-processed foods to cardiometabolic health should not delay public health policies aimed at reducing their consumption. No empirical data, study populations, or statistical findings are reported in the abstract.
Touvier M, da Costa Louzada ML, Mozaffarian D, et al. BMJ, 2023. PMID 37813465
2023 / Scientific opinion on a health claim
The EFSA NDA Panel evaluated the scientific substantiation of a health claim regarding Appethyl (an aqueous spinach leaf extract) and body weight reduction based on three human intervention studies. Appethyl (5 g/day for 12 weeks) showed no effect on body weight compared to placebo under minimal dietary counselling and moderate physical activity. Additionally, weight maintenance effects (5 g/day for 24 weeks) seen in one study were not replicated, and no evidence was provided for a plausible sustained mechanism in humans. The Panel concluded that a cause-and-effect relationship has not been established under the proposed conditions of use.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, et al. EFSA J, 2023. PMID 37829005
2023 / Narrative review
This review summarizes scientific literature regarding the effects of taurine on human health, with a primary focus on aging and cardiovascular pathophysiology alongside metabolic regulation, neurological function, and athletic performance. Evidence from human and animal studies indicates potential cardiovascular benefits, including blood pressure regulation, enhanced vascular health, and improved cardiac fitness. Current recommendations for taurine intake and potential safety concerns were also addressed.
Santulli G, Kansakar U, Varzideh F, et al. Nutrients, 2023. PMID 37836520
2023 / Narrative review
This review examines semaglutide, approved for type 2 diabetes and obesity management. Manufacturer-sponsored randomized controlled trials showed a loss of almost 12% of body weight over 68 weeks, though individuals regain most of their pretreatment weight once medication is stopped. Gastrointestinal adverse events occur commonly, and pancreatitis, diabetic retinopathy, and severe allergic reactions have also been reported.
Lexchin J, Mintzes B Drug Ther Bull, 2023. PMID 37879878
2023 / Review
Obesity is a major public health concern associated with conditions like hypertension, type 2 diabetes, stroke, and cancer, affecting over a third of adults in the United States. While standard pharmacological agents such as lipase inhibitors and GLP-1 receptor agonists reduce weight gain by inhibiting fat absorption or stimulating satiety hormones, they are not effective for genetic disorders like Bardet-Biedl syndrome or POMC deficiency. Emerging therapies, including leptin analogs and MC4R agonists, target these genetic or hormonal causes to help regulate energy balance and appetite. The review discusses clinical trials, efficacy, FDA-approved indications, contraindications, and serious side effects of these medication classes.
Brandfon S, Eylon A, Khanna D, et al. Cureus, 2023. PMID 37937009
2023 / Narrative review
This narrative review examined position papers published by scientific, professional, and paediatric associations regarding vegan diets during infancy, childhood, and adolescence. Some associations support well-designed vegan diets with vitamin B12 supplementation and medical oversight, while others caution against them, citing potential harm, lack of substantiation, or reliance on lower-quality or outdated studies. The authors highlight the need for an up-to-date literature review and comparable assessments of both omnivorous and vegan diets.
Jakše B, Fras Z, Fidler Mis N Nutrients, 2023. PMID 38004109
2023 / Narrative review with clinical case series data
The authors review dietary factors in inflammatory bowel disease and describe outcomes incorporating a lacto-ovo-semi-vegetarian plant-based diet (PBD) into inpatient and post-discharge practice. First-line therapy with infliximab and PBD achieved a remission rate of 96% (44/46) in Crohn's disease (CD) and 76% (13/17) in severe ulcerative colitis (UC). In CD, a relapse-free outcome was achieved in 52% of patients at 10-year follow-up without biologics or immunosuppressants, while cumulative relapse rates for 51 initial episode UC cases at 1 and 5 years were 14% and 27%, respectively. Additionally, PBD alone induced remission without medication in approximately one-third of mild UC cases.
Chiba M, Tsuji T, Komatsu M Transl Gastroenterol Hepatol, 2023. PMID 38021365